The global digital brain health market size accounted for USD 231.13 billion in 2024, grew to USD 248.49 billion in 2025 and is expected to be worth around USD 476.82 billion by 2034, registering a CAGR of 7.51% between 2024 and 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Digital Brain Health Market
5.1. COVID-19 Landscape: Digital Brain Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Digital Brain Health Market, By Functionality
8.1. Digital Brain Health Market, by Functionality, 2024-2034
8.1.1 Electronic Health Records (EHR)
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Care Plans/Health Management
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Financial Functionality
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Clinical Functionality
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Clinical Decision Support (CDS)
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. E-Prescribing
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Telehealth
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Administrative Functionality
8.1.8.1. Market Revenue and Forecast (2021-2034)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Digital Brain Health Market, By Component
9.1. Digital Brain Health Market, by Component, 2024-2034
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Devices
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Digital Brain Health Market, By End-User
10.1. Digital Brain Health Market, by End-User, 2024-2034
10.1.1. Specialty Clinics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Digital Brain Health Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.1.2. Market Revenue and Forecast, by Component (2021-2034)
11.1.3. Market Revenue and Forecast, by End-User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.2.2. Market Revenue and Forecast, by Component (2021-2034)
11.2.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Component (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Component (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.3.2. Market Revenue and Forecast, by Component (2021-2034)
11.3.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Component (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Component (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Component (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End-User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Component (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.5.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Component (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End-User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Functionality (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Component (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End-User (2021-2034)
Chapter 12. Company Profiles
12.1. Linus Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medibio
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. The Echo Group
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Spring Care
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Inc. Qualifacts Systems, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. NXGN Management
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Netsmart Technologies
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. IBM
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Holmusk
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Core Solutions, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample